Occurrence of clinical depression during combination therapy with pegylated interferon alpha or natural human interferon beta plus ribavirin

スポンサーリンク

概要

• 論文の詳細を見る
• 2012-03-01

著者

• NOMURA Hideyuki

  The Center for Liver Disease, Shin-Kokura Hospital

• TANIMOTO Hironori

  The Center for Liver Disease, Shin-kokura Hospital

• MIYAGI Yuugou

  The Center for Liver Disease, Shin-kokura Hospital

• YAMASHITA Nobuyuki

  The Center for Liver Disease, Shin-kokura Hospital

• OOHASHI Seiji

  The Center for Liver Disease, Shin-kokura Hospital

• NISHIURA Saburo

  The Center for Liver Disease, Shin-kokura Hospital

関連論文

• Effective prediction of outcome of combination therapy with pegylated interferon alpha 2b plus ribavirin in Japanese patients with genotype-1 chronic hepatitis C using early viral kinetics and new indices
• Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
• Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
• Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
• Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
• An inadequate dose of ribavirin is related to virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin
• Recommendation of lamivudine-to-entecavir switching treatment in chronic hepatitis B responders : Randomized controlled trial
• Pegylated interferon α-2b plus ribavirin for Japanese chronic hepatitis C patients with normal alanine aminotransferase
• Occurrence of clinical depression during combination therapy with pegylated interferon alpha or natural human interferon beta plus ribavirin

スポンサーリンク